• August 8, 2026

CoreAge Rx Adds Bounce Back Copper Peptide Night Cream to Prescription Skincare Offerings

Brand News 24 | August 6, 2026

The new nighttime topical delivers a 0.2% copper peptide concentration to assist with overnight skin barrier repair and firmness.

Wichita Falls, TX, United States, 6th Aug 2026 - Digital healthcare provider CoreAge Rx has expanded its dermatology line with Bounce Back, a prescription repair cream. Formulated specifically for nighttime application, the topical product is designed to support skin resilience, improve firmness, and reinforce the natural moisture barrier while the body undergoes its standard nocturnal repair cycle.

CoreAge Rx Adds Bounce Back Copper Peptide Night Cream to Prescription Skincare Offerings

The primary active component in Bounce Back is a 0.2% concentration of copper peptides. This specific compound was selected to encourage structural elasticity and help the skin recover from daily environmental exposure. Compounded in the United States, the cream offers rich hydration in a lightweight base that absorbs easily for regular evening use, helping to smooth the appearance of fine lines over time.

Because Bounce Back is a prescription-grade product, it is available exclusively through the CoreAge Rx telehealth platform. Prospective users complete a secure online health questionnaire, which a US-based physician reviews to ensure the treatment is medically appropriate. Once authorized, individuals are directed to apply a thin layer to clean, dry skin at night. Clinicians may suggest adjustments to the application frequency depending on individual skin tolerance, and they strongly advise users to apply daily sunscreen while using the product.

Consumers can access Bounce Back starting at $64.99 per month. CoreAge Rx utilizes a straightforward pricing structure that includes the online medical evaluation, the compounded cream, and home delivery, without requiring long-term contracts or mandatory membership fees.

This addition to the CoreAge Rx catalog reflects the company's approach to accessible dermatology and longevity. Individuals using the platform receive their prescription therapies alongside continuous access to healthcare providers, a dedicated support team, and an interactive community network.

To read more about the role of copper peptides in nighttime skin recovery, view the featured article: CoreAge Rx Introduces Bounce Back, a Restorative Nighttime Copper Peptide Cream for Visible Firmness and Skin Barrier Repair.

For full product details or to initiate a medical consultation, visit https://www.coreagerx.com/product/bounce-back/

About CoreAge Rx 

CoreAge Rx is a digital health organization that coordinates virtual medical consultations, prescription treatments, and functional supplements. The platform connects patients with US-based doctors to address metabolic health, preventive longevity, and targeted dermatology. CoreAge Rx focuses on providing practical and accessible care options that fit into everyday routines.

For more information, visit coreagerx.com

 


 

Media Contact

Organization: CoreAge Rx

Contact Person: Ella Jones

Website: https://www.coreagerx.com/

Email: Send Email

Contact Number: +19404004927

City: Wichita Falls

State: TX

Country:United States

Release id:47925

The post CoreAge Rx Adds Bounce Back Copper Peptide Night Cream to Prescription Skincare Offerings appeared first on King Newswire. This content is provided by a third-party source.. King Newswire is a press release distribution agency. We do not accept any responsibility or liability for the accuracy, content, images, videos, licences, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section above.

file

Disclaimer: The views, recommendations, and opinions expressed in this content belong solely to the third-party experts. This site was not involved in the writing and production of this article.

disclaimer_press_release